COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 2593: Articles 25921-25930  | Next

Population density and basic reproductive number of COVID-19 across United States counties
Sy, K. T. L., White, L. F., Nichols, B. E.
10.1101/2020.06.12.20130021 — Posted: 2020-06-13
Heterogeneity in risk, testing and outcome of COVID-19 across outbreak settings in the Greater Toronto Area, Canada: an observational study
Wang, L., Ma, H., Yiu, K. C. Y., Calzavara, A., Landsman, D., Luong, L., Chan, A. K., Kustra, R., Kwong, J. C., Boily, M.-C., Hwang, S., Straus, S., Baral, S., Mishra, S.
10.1101/2020.06.12.20129783 — Posted: 2020-06-13
Analysis of SARS-CoV-2 Genomes from Southern California Reveals Community Transmission Pathways in the Early Stage of the US COVID-19 Pandemic
Zhang, W., Govindavari, J. P., Davis, B., Chen, S. C., Kim, J. T., Song, J., Lopategui, J., Plummer, J. T., Vail, E.
10.1101/2020.06.12.20129999 — Posted: 2020-06-13
DeepEMhacer: a deep learning solution for cryo-EM volume post-processing
Sanchez Garcia, R., Gomez-Blanco, J., Cuervo, A., Carazo, J. M., Sorzano, C. O. S., Vargas, J.
10.1101/2020.06.12.148296 — Posted: 2020-06-13
Cystal structure of inhibitor-bound human MSPL/TMPRSS13 that can activate high pathogenic avian influenza
Ohno, A., Maita, N., Tabata, T., Nagano, H., Arita, K., Ariyoshi, M., Uchida, T., Nakao, R., Ulla, A., Sugiura, K., Kishimoto, K., Teshima-Kondo, S., Nikawa, T., Okumura, Y.
10.1101/2020.06.12.149229 — Posted: 2020-06-13
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
Finney, L. J., Glanville, N., Farne, H., Aniscenko, J., Fenwick, P., Kemp, S., Trujillo-Torralbo, M.-B., Calderazzo, M., Wedzicha, J. A., Mallia, P., Bartlett, N. W., Johnston, S. L., Singanayagam, A.
10.1101/2020.06.13.149039 — Posted: 2020-06-13 Discussion: Onsite | Offsite
Colon Cancer and SARS-CoV-2: Impact of ACE2 Expression in Susceptibility to COVID-19
Ahmadi, M., Saffarzadeh, N., Amin Habibi, M., Hajiesmaeili, F., Rezaei, N.
10.1101/2020.06.11.146878 — Posted: 2020-06-13
Multi-epitope Based Peptide Vaccine Design Using Three Structural Proteins (S, E, and M) of SARS-CoV-2: An In Silico Approach
Roy, A. S., Quadery Tonmoy, M. I., Fariha, A., Hami, I., Khalil Afif, I., Munim, M. A., Alam, M. R., Hossain, M. S.
10.1101/2020.06.13.149880 — Posted: 2020-06-13
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
Zhou, D., Duyvesteyn, H. M. E., Chen, C.-P., Huang, C.-G., Chen, T.-H., Shih, S.-R., Lin, Y.-C., Cheng, C.-Y., Cheng, S.-H., Huang, Y.-C., Lin, T.-Y., Ma, C., Huo, J., Carrique, L., Malinauskas, T., Ruza, R. R., Shah, P., Tan, T. K., Rijal, P., Donat, R. F., Godwin, K., Buttigieg, K., Tree, J., Radecke, J., Paterson, N. G., Supasa, P., Mongkolsapaya, J., Screaton, G. R., Carroll, M. W., Jaramillo, J. G., Knight, M., James, W. S., Owens, R. J., Naismith, J. H., Townsend, A., Fry, E. E., Zhao, Y., Ren, J., Stuart, D. I., Huang, K.-Y. A.
10.1101/2020.06.12.148387 — Posted: 2020-06-13
Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4+ T cells
Meckiff, B. J., Ramirez-Suastegui, C., Fajardo, V., Chee, S. J., Kusnadi, A., Simon, H., Grifoni, A., Pelosi, E., Weiskopf, D., Sette, A., Ay, F., Seumois, G., Ottensmeier, C., Vijayanand, P.
10.1101/2020.06.12.148916 — Posted: 2020-06-13 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).